Skip to main content

Table 3 Associations between SNPs in PHF11, DPP10, HLA-G and asthma or asthma-related phenotypes, adjusted for age, gender, height, weight, BMI and smoking status.

From: Analyses of associations between three positionally cloned asthma candidate genes and asthma or asthma-related phenotypes in a Chinese population

Gene

Phenotype

SNP

Genotype

Negative

N (%)

Positive

N (%)

OR (95% CI)

Nominal

P Value

PHF11

SPTa

rs2247119

TT

167 (35.9)

161 (30.8)

1

 
   

CT

213 (45.8)

263 (50.3)

1.27 (0.95-1.67)

0.10

   

CC

85 (18.3)

99 (18.9)

1.14 (0.79-1.65)

0.48

    

Dominant Model

 

1.23 (0.94-1.61)

0.13

 

SPT + Asthma b

rs2247119

TT

138 (35.8)

109 (32.2)

1

 
   

CT

179 (46.5)

169 (49.9)

1.18 (0.84-1.65)

0.35

   

CC

68 (17.7)

61 (18.0)

1.08 (0.69-1.67)

0.74

    

Dominant Model

 

1.15 (0.84-1.58)

0.39

DPP10

MTCH Challengec

rs10192393

TT

404 (92.0)

393 (86.2)

1

 
   

CT

34 (7.7)

62 (13.6)

1.91 (1.21-3.03)

0.0059

   

CC

1 (0.2)

1 (0.2)

1.46 (0.09-23.56)

0.79

    

Dominant Model

 

1.90 (1.20-3.00)

0.0059

 

MTCH Challenge + Asthma d

rs10192393

TT

360 (92.3)

284 (85.8)

1

 
   

CT

29 (7.4)

46 (13.9)

2.04 (1.22-3.42)

0.0070

   

CC

1 (0.3)

1 (0.3)

1.66 (0.10-27.13)

0.72

    

Dominant Model

 

2.03 (1.22-3.37)

0.0067

HLA-G

MTCH Challenge

rs1736935

CC

150 (32.6)

191 (37.5)

1

 
   

CT

227 (49.3)

241 (47.3)

0.82 (0.61-1.09)

0.17

   

TT

83 (18.0)

77 (15.1)

0.73 (0.49-1.07)

0.10

    

Additive Model

 

0.85 (0.70-1.02)

0.079

 

MTCH Challenge + Asthma

rs1736935

CC

136 (33.9)

152 (39.3)

1

 
   

CT

192 (47.9)

181 (46.8)

0.84 (0.61-1.15)

0.27

   

TT

73 (18.2)

54 (14.0)

0.64 (0.41-0.99)

0.044

    

Additive Model

 

0.81 (0.65-0.99)

0.043

  1. a: Skin prick test. A positive skin prick test was defined as at least one antigen-induced wheal size >2 mm of the saline control value.
  2. b: Combined asthma status and skin prick test. All cases were asthmatic with a positive skin test result, while all controls were non-asthmatic with a negative skin test result.
  3. c: Airway methacholine challenge test. Negative and positive responses were defined as no PD20 observed and a PD20 observed in the test, respectively.
  4. d: Combined asthma status and methacholine challenge test. All cases were asthmatic with a positive challenge test result, while all controls were non-asthmatic with a negative challenge test result.